Literature DB >> 22211133

Donating tissue for research: patient and provider perspectives.

Allison R Baer1, Mary Lou Smith, Johanna C Bendell.   

Abstract

This article illustrates common patient and provider concerns about donating tissue for the purpose of research, discusses best practices, and provides answers to common patient questions.

Entities:  

Year:  2011        PMID: 22211133      PMCID: PMC3170069          DOI: 10.1200/JOP.2011.000399

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  7 in total

1.  Why surgical patients do not donate tissue for commercial research: review of records.

Authors:  Alison L Jack; Christopher Womack
Journal:  BMJ       Date:  2003-08-02

2.  Maximising recruitment into randomised controlled trials: the role of multidisciplinary cancer teams.

Authors:  A G K McNair; C T P Choh; C Metcalfe; D Littlejohns; C P Barham; A Hollowood; S J Falk; J M Blazeby
Journal:  Eur J Cancer       Date:  2008-09-18       Impact factor: 9.162

3.  Strategic physician communication and oncology clinical trials.

Authors:  T L Albrecht; C Blanchard; J C Ruckdeschel; M Coovert; R Strongbow
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

4.  High rate of consent to bank biologic samples for future research: the Eastern Cooperative Oncology Group experience.

Authors:  Thomas Malone; Paul J Catalano; Peter J O'Dwyer; Bruce Giantonio
Journal:  J Natl Cancer Inst       Date:  2002-05-15       Impact factor: 13.506

5.  Breast cancer patients' attitudes toward clinical trials in the radiation oncology clinic versus those searching for trial information on the Internet.

Authors:  Christopher M Dolinsky; S Jack Wei; Margaret K Hampshire; James M Metz
Journal:  Breast J       Date:  2006 Jul-Aug       Impact factor: 2.431

6.  Influence of clinical communication on patients' decision making on participation in clinical trials.

Authors:  Terrance L Albrecht; Susan S Eggly; Marci E J Gleason; Felicity W K Harper; Tanina S Foster; Amy M Peterson; Heather Orom; Louis A Penner; John C Ruckdeschel
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

7.  American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.

Authors:  Robin Zon; Neal J Meropol; Robert B Catalano; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2008-04-07       Impact factor: 44.544

  7 in total
  5 in total

1.  Knowledge and willingness to provide research biospecimens among foreign-born Latinos using safety-net clinics.

Authors:  Christopher A Loffredo; Gheorghe Luta; Sherrie Wallington; Solomon B Makgoeng; Claire Selsky; Jeanne S Mandelblatt; Lucile L Adams-Campbell
Journal:  J Community Health       Date:  2013-08

2.  Broad Consent for Research on Biospecimens: The Views of Actual Donors at Four U.S. Medical Centers.

Authors:  Teddy D Warner; Carol J Weil; Christopher Andry; Howard B Degenholtz; Lisa Parker; Latarsha J Carithers; Michelle Feige; David Wendler; Rebecca D Pentz
Journal:  J Empir Res Hum Res Ethics       Date:  2018-02-01       Impact factor: 1.742

3.  Tumor acquisition for biomarker research in lung cancer.

Authors:  Marvaretta Stevenson; Jared Christensen; Debra Shoemaker; Traci Foster; William T Barry; Betty C Tong; Momen Wahidi; Scott Shofer; Michael Datto; Geoffrey Ginsburg; Jeffrey Crawford; Thomas D'Amico; Neal Ready
Journal:  Cancer Invest       Date:  2014-05-09       Impact factor: 2.176

4.  Ethics of clear health communication: applying the CLEAN Look approach to communicate biobanking information for cancer research.

Authors:  Alexis Koskan; Mariana Arevalo; Clement K Gwede; Gwendolyn P Quinn; Shalewa A Noel-Thomas; John S Luque; Kristen J Wells; Cathy D Meade
Journal:  J Health Care Poor Underserved       Date:  2012-11

5.  Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey.

Authors:  Sing Yu Moorcraft; Cheryl Marriott; Clare Peckitt; David Cunningham; Ian Chau; Naureen Starling; David Watkins; Sheela Rao
Journal:  Trials       Date:  2016-01-09       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.